Exact Sciences
EXAS
#1548
Rank
$11.17 B
Marketcap
$60.37
Share price
-0.63%
Change (1 day)
-6.55%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Exact Sciences (EXAS) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : $3.53 Billion USD

According to Exact Sciences's latest financial reports the company's total liabilities are $3.53 Billion USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Exact Sciences - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31$3.32 B4.47%
2022-12-31$3.18 B-3.44%
2021-12-31$3.29 B22.6%
2020-12-31$2.68 B120.87%
2019-12-31$1.21 B44.44%
2018-12-31$0.84 B978.91%
2017-12-31$78.14 M87.19%
2016-12-31$41.74 M12.3%
2015-12-31$37.17 M55.93%
2014-12-31$23.84 M110.77%
2013-12-31$11.31 M-16.36%
2012-12-31$13.52 M0.49%
2011-12-31$13.45 M-19.71%
2010-12-31$16.76 M-14.82%
2009-12-31$19.67 M136.18%
2008-12-31$8.33 M0.29%
2007-12-31$8.3 M-6.77%
2006-12-31$8.91 M-32.62%
2005-12-31$13.22 M-27.05%
2004-12-31$18.12 M-19.26%
2003-12-31$22.45 M91.3%
2002-12-31$11.73 M183.98%
2001-12-31$4.13 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
$0.34 B-90.12%๐Ÿ‡บ๐Ÿ‡ธ USA
$98.97 M-97.20%๐Ÿ‡บ๐Ÿ‡ธ USA
$21.81 M-99.38%๐Ÿ‡บ๐Ÿ‡ธ USA
$60.84 B 1,619.69%๐Ÿ‡ซ๐Ÿ‡ท France